https://scholarworks.brandeis.edu/esploro/outputs/journalArticle/Blinatumomab-induced-T-cell-activation-at-single/9924014395401921
Blinatumomab-induced T cell activation at single cell transcriptome resolution - Brandeis University
Mar 1, 2021 - Bi-specific T-cell engager (BiTE) antibody is a class of bispecific antibodies designed for cancer immunotherapy. Blinatumomab is the first approved BiTE to...
t cell activationbrandeis universityblinatumomabinducedsingle
https://nemours.elsevierpure.com/en/publications/palbociclib-and-chemotherapy-followed-by-blinatumomab-consolidati/
Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in...
car t cellfollowed bypalbociclibchemotherapyblinatumomab
https://vyliec.sk/ucinne-latky/blinatumomab/
Blinatumomab | Vyliec.sk
Jan 30, 2024 - Latinský názov: Blinatumomab Lieky s účinnou látkou blinatumomab:
blinatumomab
https://www.aerzteblatt.de/news/erste-erfolgreiche-anwendung-von-blinatumomab-bei-systemischer-sklerose-65072522-7790-48fb-bc37-cad9e05db057
Erste erfolgreiche Anwendung von Blinatumomab bei systemischer Sklerose – News – Deutsches...
ersteerfolgreicheanwendungvonblinatumomab
https://www.pharmacytimes.com/view/ash-2024-pharmacists-play-key-role-in-incorporating-venetoclax-blinatumomab-for-treatment-of-malignancies
ASH 2024: Pharmacists Play Key Role in Incorporating Venetoclax, Blinatumomab for Treatment of...
Oct 15, 2026 - Amir Ali, PharmD, BCOP highlights the success of shorter-treatment duration venetoclax in patients with acute myeloid leukemia and efficacy of pre-transplant...
key roleashpharmacistsplayincorporating
https://publires.unicatt.it/en/publications/immunomodulatory-effect-of-dasatinib-plus-blinatumomab-versus-pon/
immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib blinatumomab in newly...
immunomodulatoryeffectdasatinibplusblinatumomab
https://database.inahta.org/article/33413
[Blinatumomab (first relapsed
blinatumomabfirstrelapsed
https://www.cmladvocates.net/clinical_trials/asciminib-dasatinib-prednisone-blinatumomab-in-bcr-abl-b-all-or-cml-usa/
Asciminib + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML [USA] | CML Advocates...
asciminibdasatinibprednisoneblinatumomabbcr
https://cme.utsouthwestern.edu/193-012319
193 Hematology/Hematopathology Case Conference: "Unusual Relapse After Blinatumomab; Breast-...
case conferencehematologyhematopathologyunusualrelapse